Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

GYRE — Gyre Therapeutics, Inc.

N/A · Quality 39/100

Value Score 30 days ago: 6 → today 28

GYRE - Gyre Therapeutics, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 4.26 USD
Intrinsic value: 0.28 USD
Margin of safety: -1600.0%
Implied growth (reverse DCF): +60.0% (model assumes +6.0%)
Valuation: N/A
Value Score: 28
Quality: 39/100
Moat score: 46.8 (erosion: none)
N/A - Quality 39/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/GYRE
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

4.26

Intrinsic value

0.28

Margin of safety

-1600.0%

Implied growth (reverse DCF)

+60.0%

model assumes +6.0%

Value Score

Quality

Psychology

43.6

Discovery

12.5

price/volume attention only

Moat score

46.8

erosion: none

Value Score: bottom 46% of Russell 3000 · Quality: bottom 25%

Open the interactive Deep Dive for GYRE →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/GYRE - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is Gyre Therapeutics, Inc.'s Value Score?

Gyre Therapeutics, Inc.'s Value Score is 28 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.